The company aims to become the global leader in Mānuka Honey-based nutraceuticals, science and innovation. Mānuka Performance provides athletes, weekend warriors and active lifestylers natural, Mānuka honey-based nutrition, with professionals, teams, national organizations and everyday people continuing to use and see results from their unique, high performance products.
Cyborg Score Rationale
The company demonstrates strong market positioning with international research partnerships, proven product efficacy backed by clinical data, and growing expansion into the U.S. market. However, limited public financial data and private company status constrain visibility on scale and profitability.
Top Insights
The company sits at the forefront of natural health sciences, combining robust R&D, strong consumer feedback, and trending product pathways across multiple global market segments.
Recent USA clinical survey results showed a 92% overall approval rating on their Immuno Support snaps and a 95% re-order result.
Mānuka honey is consumed in at least 60 countries around the world.
All products are designed, endorsed, and recommended by their Chief Medical Officer, leading surgeon Dr Marc S. Stevens MD.
Named Competitors
Manuka Health — Premium Mānuka honey and bee products for immunity and wellness
Other Honey-Based Nutraceuticals — General honey and natural supplement products
Recent Developments
(April 2024) USA market launch with pre-order shipping announced
(2024) Clinical validation of Immuno Support product line with 92% approval rating
Product expansion into gut health, immunity support, and sports nutrition segments
Open the full interactive Manuka Performance USA, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.